合眾思壯(002383.SZ):子公司擬向天派電子購買一批機器設備 交易價格為1376.07萬元
格隆匯 12 月 29日丨合眾思壯(002383.SZ)公佈,公司於2020年12月28日召開第四屆董事會第八十五次會議、第四屆監事會第三十六次會議,審議通過了《關於向天派電子(深圳)有限公司購買機器設備暨關聯交易的議案》。
公司控股子公司合眾智造(河南)科技有限公司(“合眾智造”)因生產需要,擬向天派電子(深圳)有限公司(“天派電子”)購買一批機器設備,交易價格為1376.0688萬元人民幣(含税價)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.